141 related articles for article (PubMed ID: 20077549)
1. Selective aggregation of a platinum-gadolinium complex within a tumor-cell nucleus.
Crossley EL; Aitken JB; Vogt S; Harris HH; Rendina LM
Angew Chem Int Ed Engl; 2010 Feb; 49(7):1231-3. PubMed ID: 20077549
[No Abstract] [Full Text] [Related]
2. Ruthenium(II) metallo-intercalators: DNA imaging and cytotoxicity.
Gill MR; Derrat H; Smythe CG; Battaglia G; Thomas JA
Chembiochem; 2011 Apr; 12(6):877-80. PubMed ID: 21433240
[No Abstract] [Full Text] [Related]
3. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
[TBL] [Abstract][Full Text] [Related]
5. An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug.
Huxley M; Sanchez-Cano C; Browning MJ; Navarro-Ranninger C; Quiroga AG; Rodger A; Hannon MJ
Dalton Trans; 2010 Dec; 39(47):11353-64. PubMed ID: 21031218
[TBL] [Abstract][Full Text] [Related]
6. Studying the interactions of a platinum(II) 9-aminoacridine complex with proteins and oligonucleotides by ESI-TOF MS.
Samper KG; Vicente C; Rodríguez V; Atrian S; Cutillas N; Capdevila M; Ruiz J; Palacios Ò
Dalton Trans; 2012 Jan; 41(1):300-6. PubMed ID: 22089173
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of platinum anticancer agents--what do we really know about it?
Gibson D
Dalton Trans; 2009 Dec; (48):10681-9. PubMed ID: 20023895
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
[TBL] [Abstract][Full Text] [Related]
9. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
10. New Au (III), Pt (II) and Pd (II) complexes with pentapeptide glycyl-glycyl-(L)-methyonyl-glycyl-glycine and their interaction with calf thymus DNA.
Chapkanov A; Miteva Y; Kolev T; Spiteller M; Koleva B
Protein Pept Lett; 2010 Feb; 17(2):228-37. PubMed ID: 19508228
[TBL] [Abstract][Full Text] [Related]
11. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
Manna CM; Tshuva EY
Dalton Trans; 2010 Feb; 39(5):1182-4. PubMed ID: 20104339
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC
Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922
[TBL] [Abstract][Full Text] [Related]
13. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
14. A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.
Yuan Y; Chen Y; Tang BZ; Liu B
Chem Commun (Camb); 2014 Apr; 50(29):3868-70. PubMed ID: 24589580
[TBL] [Abstract][Full Text] [Related]
15. A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins.
Marques J; Santos TM; Marques MP; Braga SS
Dalton Trans; 2009 Nov; (44):9812-9. PubMed ID: 19885528
[TBL] [Abstract][Full Text] [Related]
16. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: distribution in tumour cells.
Wu S; Wang X; Zhu C; Song Y; Wang J; Li Y; Guo Z
Dalton Trans; 2011 Oct; 40(40):10376-82. PubMed ID: 21681330
[TBL] [Abstract][Full Text] [Related]
17. A thiazoline-containing cobalt(II) complex based colorimetric fluorescent probe: "turn-on" detection of fluoride.
Wang J; Liu HB; Wang W; Kim I; Ha CS
Dalton Trans; 2009 Dec; (47):10422-5. PubMed ID: 20023861
[TBL] [Abstract][Full Text] [Related]
18. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
Ronconi L; Fregona D
Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
[TBL] [Abstract][Full Text] [Related]
19. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective PTP1B inhibition by a platinum(ii) complex: possible implications for a new antitumor strategy.
Yuan C; Wang W; Wang J; Li X; Wu YB; Li S; Lu L; Zhu M; Xing S; Fu X
Chem Commun (Camb); 2019 Dec; 56(1):102-105. PubMed ID: 31793564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
